Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic

Yıl: 2021 Cilt: 19 Sayı: 1 Sayfa Aralığı: 1 - 5 Metin Dili: İngilizce DOI: 10.21911/aai.603
hred

Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic

Öz:
Nebulizers generate aerosols and may potentially transmit respiratory viral particles including SARS-CoV-2. There is a great concernabout the use of a nebulizer in the treatment of asthma exacerbations in the hospital or home setting during the COVID-19 pandemicand its use is not recommended unless essential. However, aerosol therapy should not be avoided in obligatory indications. Therefore,indications of nebulizer use during the pandemic should be evaluated on an individual basis in case of a severe asthma attack, andinfection control recommendations should be followed by clinicians while using nebulizers. In this article, we aimed to assess the safetyin addition to the “pro” and “con” sides of nebulizer treatment in asthma exacerbation during the COVID-19 pandemic.
Anahtar Kelime:

Konular:
Fen > Tıp > Alerji
Fen > Tıp > İmmünoloji
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Global strategy for asthma management and prevention. Global Initiative for Asthma Web site. http://www.ginasthma. org. Updated 2020. Accessed December 20, 2020.
  • 2. Türkiye Ulusal Allerji ve Klinik İmmünoloji Derneği ve Türk Toraks Derneği. Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi. Çelik G (ed). Aralık 2020.
  • 3. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al; American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-71.
  • 4. Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in allergy practice during the COVID-19 pandemic. Int Arch Allergy Immunol 2021;182(1):49-52.
  • 5. Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: A serious, underappreciated risk. CMAJ 2020;192:E346.
  • 6. Soyer Ö, Kahveci M, Büyüktiryaki B, Arık Yılmaz E, Karaatmaca B, Esenboğa S, et al. Mesh nebulizer is as effective as jet nebulizer in clinical practice of acute asthma in children. Turk J Med Sci 2019;49(4):1008-13.
  • 7. Hui DS, Chow BK, Chu LC, Ng SS, Hall SD, Gin T, et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009;135:648-54.
  • 8. Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020;582:557-60.
  • 9. Wan GH, Tsai YH, Wu YK, Tsao KC. A large volume nebulizer would not be an infectious source for severe acute respiratory syndrome. Infect Control Hosp Edidemiol 2004;25:1113-5.
  • 10. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564-7.
  • 11. Heinzerling A, Stuckey MJ, Scheuer T, Xu K, Perkins KM, Resseger H, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient - Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 2020:17;69(15):472-6.
  • 12. Tang JW, Li Y, Eames I, Chan PKS, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006;64:100– 14.
  • 13. Tang JW, Kalliomaki P, Varila TM, Waris M, Koskela H. Nebulisers as a potential source of airborne virus. J Infect 2020; 81(4): 647–9.
  • 14. Ari A. Use of aerosolised medications at home for COVID-19. Lancet Respir Med 2020;8(8):754-6.
  • 15. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: severe asthma. [Internet]. 2020. Available from: https://www.guidelines.co.uk/covid-19-rapidguideline-severeasthma/455275.article
  • 16. Ozturk AB, Bavbek S. Role of SARS-CoV-2 in asthma exacerbations. Asthma Allergy Immunol 2020;18 (Supplement 1): 8-10.
  • 17. Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med 2020;167:105987.
  • 18. Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013;2013(9):CD000052.
  • 19. Chinese Medical Association Respiratory Branch, Expert consensus on protective measures related to respiratory therapy in patients with severe and critical coronavirus infection. Chin J Tuberc Respir Dis 2020;17:E020.
APA CİVELEK E, BAVBEK S, ÖZTÜRK A, BACCIOĞLU A, SOYER Ö, ŞEKEREL B (2021). Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji, 19(1), 1 - 5. 10.21911/aai.603
Chicago CİVELEK ERSOY,BAVBEK Sevim,ÖZTÜRK Ayşe Bilge,BACCIOĞLU Ayşe,SOYER Özge,ŞEKEREL Bülent Enis Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji 19, no.1 (2021): 1 - 5. 10.21911/aai.603
MLA CİVELEK ERSOY,BAVBEK Sevim,ÖZTÜRK Ayşe Bilge,BACCIOĞLU Ayşe,SOYER Özge,ŞEKEREL Bülent Enis Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji, vol.19, no.1, 2021, ss.1 - 5. 10.21911/aai.603
AMA CİVELEK E,BAVBEK S,ÖZTÜRK A,BACCIOĞLU A,SOYER Ö,ŞEKEREL B Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji. 2021; 19(1): 1 - 5. 10.21911/aai.603
Vancouver CİVELEK E,BAVBEK S,ÖZTÜRK A,BACCIOĞLU A,SOYER Ö,ŞEKEREL B Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic. Astım Allerji İmmünoloji. 2021; 19(1): 1 - 5. 10.21911/aai.603
IEEE CİVELEK E,BAVBEK S,ÖZTÜRK A,BACCIOĞLU A,SOYER Ö,ŞEKEREL B "Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic." Astım Allerji İmmünoloji, 19, ss.1 - 5, 2021. 10.21911/aai.603